Distributors acquire in Asia

Azelis, has acquired the distribution business of S. Amit Group, a Mumbai-based distributor of chemicals for the pharmaceutical, agricultural and CASE markets in India. The deal, for which terms were not disclosed, should be completed within Q2.

S. Amit employs 16 and supplies raw materials for APIs and agrochemical AIs, among other things. Azelis said that S. Amit’s “expertise and offerings across industries” complement its existing lateral value chain in the domestic market”.

“Our combined expertise and technical support unlock new opportunities for customers and allow principals to strengthen their partnership with a world-class innovation service provider,” Azelis commented. “It also allows them to tap into the teams’ deep technical knowledge and innovative formulations that will further grow their businesses.”

Separately, Barentz has entered into exclusive discussions to acquire 100% equity of Fengli Group, one of the largest distributors of pharmaceutical excipients and APIs in China. No date or cost has been put on the deal as yet. 

The company described this as a strategic move to gain access to the Chinese pharma market and enhance its service and commercial capabilities there, while also enabling Fengli to expand its international presence. Plans are for current president Dexin Ma to remain at the helm.

Based in Beijing, Fengli employs of over 100 across five locations in mainland China. It sources excipients and APIs from 35 international principals and supplies more than 2,000 customers in R&D and production. It has an analytical pharma lab for product formulation and support, as well as excipient R&D and application labs.